Yusuke Nakamura to Erlotinib Hydrochloride
This is a "connection" page, showing publications Yusuke Nakamura has written about Erlotinib Hydrochloride.
Connection Strength
0.178
-
WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer. Sci Rep. 2017 01 19; 7:40664.
Score: 0.147
-
VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res. 2014 May 28; 16(3):R53.
Score: 0.031